Notifytherapeutics
Aarhus, DK · Founded 2021 · 9 employees on LinkedIn · 1 known investors
Find your way into Notifytherapeutics
Notify develops pharmaceutical treatments for women with diminished ovarian reserves by targeting dormant follicle activation through NRF2 pathway modulation. The company's approach addresses early-stage egg development independent of hormonal processes, offering a potential solution for women who do not benefit from existing fertility treatments.
Founders & leadership
Notifytherapeutics was founded in 2021 by Karin Lykke-Hartmann.
KL
Karin Lykke-HartmannChief Executive Officer & Founder
Investors · 1
Frequently asked questions
- What does Notifytherapeutics do?
- Notify develops pharmaceutical treatments for women with diminished ovarian reserves by targeting dormant follicle activation through NRF2 pathway modulation. The company's approach addresses early-stage egg development independent of hormonal processes, offering a potential solution for women who do not benefit from existing fertility treatments.
- Who founded Notifytherapeutics?
- Notifytherapeutics was founded by Karin Lykke-Hartmann in 2021.
- Who are Notifytherapeutics's investors?
- Notifytherapeutics's investors include +ND Capital.
- Where is Notifytherapeutics headquartered?
- Notifytherapeutics is headquartered in Aarhus, DK.